Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Angelo Auricchio , Anne B Curtis Added: 1 year ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed… View more
Author(s): Samir R Kapadia Added: 1 year ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more
Dr Richard Schatz is research director of cardiovascular interventions at the Scripps Heart, Lung, and Vascular Center and director of gene and stem cell therapy. A recognized international expert in interventional cardiology, he has published and lectured extensively. His seminal work in coronary stents spurred a revolution in the treatment of coronary artery disease – more than 2 million of… View more
Job title: Cardiology Registrar and NIHR Clinical Lecturer
Clinical academic cardiologist with specialist interest in valvular heart disease, heart failure and multimodality imaging. BHF Intermediate Clinical Research Fellow and Senior Lecturer in Cardiology at UCL; Honorary Consultant Cardiologist at Barts Health . Investigates myocardial fibrosis in aortic stenosis using cardiovascular magnetic resonance, cardiac CT and myocardial biopsies. Current… View more
Author(s): Christian Sohns , Philipp Sommer Added: 1 year ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801). CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are… View more
Job title: Consultant Cardiologist
Dr Henry J Dargie is Consultant Cardiologist at Western Infirmary, Glasgow, and Director of the National Advanced Heart Failure Service, Glasgow (1980-2010) Research Achievements Metolozone in renal failure and heart failure Total Body Potassium in heart and renal failure Early work on role of SNS in hypertension Early RCT work on role of captopril in HF LVH and ventricular arrhythmias… View more
Job title: MD
Dr Asnani is Associate Director and an attending physician in the Cardio-Oncology Program at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts and is an active researcher in the field. She joined BIDMC in 2017 and prior to this worked at the Massachusetts General Hospital. She earned her medical degree at the Duke School of Medicine, Durham, North Carolina in 2008, one of the… View more